This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ives, T. J.
Right arrow Articles by Kebede, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ives, T. J.
Right arrow Articles by Kebede, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Mar 1997, 578-582, Vol 41, No. 3
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent- antibody analysis of infected Vero cell monolayers

TJ Ives, P Manzewitsch, RL Regnery, JD Butts and M Kebede
School of Pharmacy, University of North Carolina at Chapel Hill 27599- 7595, USA. tjives@med.unc.edu

The in vitro susceptibilities of Bartonella (Rochalimaea) henselae, B. quintana, B. elizabethae, Rickettsia akari, R. conorii, R. prowazekii, and R. rickettsii to different concentrations of azithromycin, clarithromycin, dirithromycin, erythromycin, and roxithromycin in Vero cell cultures were evaluated. Bartonella and Rickettsia spp. were allowed to initiate infection of the antibiotic-free Vero cell monolayers, which were maintained in 16-chamber microscope slides in the absence of antibiotics at 32 degrees C in a CO2-enriched atmosphere. The monolayers were then incubated for 3 h to allow for initial host cell intracellular penetration by infecting species. After inoculation, inocula were replaced and tested with media containing 12 different concentrations of each antibiotic in replicate (10 wells of each antibiotic dilution) for each species, and the monolayers were reincubated. Tetracycline served as the control. Growth status of Bartonella spp. and Rickettsia spp. was determined by evaluation of immunofluorescent staining bacilli. Five days later, when antibiotic- free, control-infected cell monolayers demonstrated significant fluorescence, media were removed for all cell monolayers, the monolayers were fixed, and all specimens were stained with standard indirect immunofluorescent antibody reagents. Fluorescent foci were enumerated by counting such foci on random fields visualized with an epifluorescence microscope. The extent of antibiotic-induced focus inhibition was recorded for each dilution of antibiotic and compared with that of an antibiotic-negative control. Effective antibiotic dilution endpoints for inhibition of Bartonella and Rickettsia proliferation, as judged by absence of increase of significant fluorescence (as compared with no-growth controls), were enumerated by determining the number of cell culture chambers at various antibiotic dilutions that were negative or positive for significant Bartonella- or Rickettsia-specific fluorescence. All of the macrolide agents tested were readily active against all three Bartonella organisms, and azithromycin, clarithromycin, and roxithromycin may have potential in the treatment of Rickettsia infections. Animal model-based clinical trials are warranted to define the specific treatment role of the newer macrolide antibiotics.


This article has been cited by other articles:

  • Florin, T. A., Zaoutis, T. E., Zaoutis, L. B. (2008). Beyond Cat Scratch Disease: Widening Spectrum of Bartonella henselae Infection. Pediatrics 121: e1413-e1425 [Abstract] [Full Text]  
  • Dorbecker, C., Sander, A., Oberle, K., Schulin-Casonato, T. (2006). In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. J Antimicrob Chemother 58: 784-788 [Abstract] [Full Text]  
  • Pendle, S., Ginn, A., Iredell, J. (2006). Antimicrobial susceptibility of Bartonella henselae using Etest methodology. J Antimicrob Chemother 57: 761-763 [Abstract] [Full Text]  
  • Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J., Raoult, D. (2004). Recommendations for Treatment of Human Infections Caused by Bartonella Species. Antimicrob. Agents Chemother. 48: 1921-1933 [Full Text]  
  • Rolain, J.-M., Stuhl, L., Maurin, M., Raoult, D. (2002). Evaluation of Antibiotic Susceptibilities of Three Rickettsial Species Including Rickettsia felis by a Quantitative PCR DNA Assay. Antimicrob. Agents Chemother. 46: 2747-2751 [Abstract] [Full Text]  
  • Nir-Paz, R., Prevost, M.-C., Nicolas, P., Blanchard, A., Wroblewski, H. (2002). Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to Membrane-Active Peptides and Enrofloxacin in Human Tissue Cell Cultures. Antimicrob. Agents Chemother. 46: 1218-1225 [Abstract] [Full Text]  
  • Vester, B., Douthwaite, S. (2001). Macrolide Resistance Conferred by Base Substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45: 1-12 [Full Text]  
  • Wood, D. O., Azad, A. F. (2000). Genetic Manipulation of Rickettsiae: a Preview. Infect. Immun. 68: 6091-6093 [Full Text]  
  • Kuzman, I. (2000). Failure of Azithromycin in Treatment of Brill-Zinsser Disease. Antimicrob. Agents Chemother. 44: 1737-1738 [Abstract] [Full Text]  
  • Rolain, J.-M., Maurin, M., Bryskier, A., Raoult, D. (2000). In Vitro Activities of Telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44: 1391-1393 [Abstract] [Full Text]  
  • Jensen, W. A., Fall, M. Z., Rooney, J., Kordick, D. L., Breitschwerdt, E. B. (2000). Rapid Identification and Differentiation of Bartonella Species Using a Single-Step PCR Assay. J. Clin. Microbiol. 38: 1717-1722 [Abstract] [Full Text]  
  • Ives, T. J., Marston, E. L., Regnery, R. L., Butts, J. D., Majerus, T. C. (2000). In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. J Antimicrob Chemother 45: 305-310 [Abstract] [Full Text]  
  • Sobraquès, M., Maurin, M., Birtles, R. J., Raoult, D. (1999). In Vitro Susceptibilities of Four Bartonella bacilliformis Strains to 30 Antibiotic Compounds. Antimicrob. Agents Chemother. 43: 2090-2092 [Abstract] [Full Text]  
  • Rolain, J. M., Maurin, M., Vestris, G., Raoult, D. (1998). In Vitro Susceptibilities of 27 Rickettsiae to 13 Antimicrobials. Antimicrob. Agents Chemother. 42: 1537-1541 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»